Focus:
Servier Pharmaceuticals is constructing Servier Paris-Saclay research institute, a new research and development hub in the Paris-Saclay cluster, France, which is one of the world’s...
Eisai China has built a new oral solid dose (OSD) production facility at its new...
Read More...
Eli Lilly announced the development of a new biomanufacturing plant in Ireland, in February 2012.
Read More...
Eirgenix, a Taiwanese contract development and manufacturing organisation (CDMO), is developing a new protein drug...
Read More...
In October 2018, Experic announced plans to develop a new manufacturing and packaging facility in...
Read More...
The Eisai Center for Genetics Guided Dementia Discovery (G2D2) is being developed at the Alewife...
Read More...
Texas Tech University along with Texas Tech University System started the construction of the new...
Read More...
European Molecular Biology Laboratory (EMBL) is developing a new facility within the Barcelona Biomedical Research...
Read More...
Emulate inaugurated a new headquarters and laboratory at Drydock Avenue in Seaport District, Boston, in...
Read More...
Eisai Knowledge Centre is located in the Special Economic Zone at the Jawaharlal Nehru Pharma...
Read More...
Eli Lilly made a commitment to invest approximately $400m in a biologics manufacturing facility in...
Read More...
Go Top
